Demystifying the Mounjaro 5 Pen: How Much Medicine is Really Inside?

Last reviewed: July 17, 2026

Last updated: July 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide pens contain a fixed concentration of medication that patients self-administer weekly to manage blood sugar and weight. Each pen is engineered to deliver exact micrograms through a mechanical dose selector, making weekly injections both safe and consistent. Understanding how these devices work helps patients make informed decisions about their treatment options.

How Much Tirzepatide Is in a Standard Pen?

A tirzepatide pen contains 2.4 milliliters of solution at a concentration designed to deliver doses ranging from 2.5 micrograms up to 15 milligrams per injection. The mechanical dial on the pen allows users to select their prescribed dose, and a subcutaneous needle injects the medication into fatty tissue below the skin. The entire delivery system is prefilled and ready to use immediately upon prescription arrival, requiring no mixing or assembly.

Each weekly injection works by binding to both GLP-1 and GIP receptors in the body, triggering appetite suppression and improved metabolic function. The tirzepatide molecule remains active for approximately seven days, which is why patients inject once weekly rather than multiple times per week. This convenient schedule supports treatment adherence and reduces the burden of daily medication management.

Understanding Tirzepatide Dose Escalation and Safety

Tirzepatide therapy typically begins at a low dose to minimize gastrointestinal side effects, then increases every four weeks under medical supervision. Most patients start at 2.5 micrograms, progress to 5 milligrams, and eventually reach maintenance doses between 10 and 15 milligrams based on individual response and tolerance. This gradual escalation allows the body to adapt to the medication while maximizing weight loss and metabolic benefits.

Clinical trials demonstrated that higher doses produced greater weight reduction compared to lower maintenance doses, with participants losing an average of 20% of baseline body weight at the maximum 15-milligram dose. However, the safest approach involves finding each patient's optimal dose—the point where benefits are maximized while side effects remain manageable. PlexusDx medical providers work with patients to identify this personalized sweet spot through regular check-ins and dose adjustments.

Compounded Tirzepatide vs. Brand-Name Pens: What's the Difference?

Brand-name tirzepatide pens and compounded tirzepatide injections deliver the same active pharmaceutical ingredient through different manufacturing pathways. Brand medications undergo extensive FDA oversight and large-scale production, while compounded versions are prepared by licensed 503A compounding pharmacies using pharmaceutical-grade tirzepatide powder. Both achieve identical clinical outcomes when properly dosed and administered.

PlexusDx compounded tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan, making weekly therapy accessible without insurance requirements or membership fees. Patients can use Health Savings Accounts or Flexible Spending Accounts to cover costs, reducing out-of-pocket expenses. PlexusDx delivers treatment to all 50 states and adjusts doses as needed without increasing the monthly price, because the pricing model is based on medication access, not dose level.

Personalized Dosing: How Genetic Insights Improve Tirzepatide Response

The PlexusDx Precision Peptide Genetic Test analyzes MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

By mapping genetic predispositions before starting treatment, PlexusDx helps patients avoid prolonged periods at subtherapeutic doses and reduces trial-and-error adjustments. The genetic test is $298 and provides actionable insights into which tirzepatide dose range aligns with your unique biology. This precision approach accelerates the path to clinical improvement and maximizes the likelihood of sustained weight loss.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

How many injections come in a tirzepatide pen?

A standard tirzepatide pen contains enough solution for four weekly injections at the same dose setting. Patients receive a new pen each month, providing 4–5 weeks of medication depending on the prescription schedule and dose adjustments ordered by their PlexusDx provider.

Can I adjust the dose on my tirzepatide pen myself?

You should never change your dose without consulting your healthcare provider. While tirzepatide pens have a mechanical dose selector, only a licensed physician should determine when and how much to increase or decrease your weekly injection based on your progress and side effects.

Does PlexusDx tirzepatide cost more if I use a higher dose?

No. PlexusDx compounded tirzepatide injections cost a flat $289/mo (or $249/mo on the 6-month plan) regardless of your dose level. Your dose may need to go up over time, but your price won't—eliminating financial barriers to optimal treatment.

What happens if I miss a weekly tirzepatide injection?

If you miss a weekly dose, take your next injection as soon as you remember, then resume your regular schedule the following week. Do not double up on doses to make up for a missed injection. Contact your PlexusDx provider if you frequently forget doses to discuss reminder strategies or alternative administration options.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

The Precision Peptide Genetic Test identifies your unique peptide-pathway genetics, including MC4R variants that influence how your body responds to tirzepatide. This information helps PlexusDx providers personalize your starting dose and escalation plan, potentially accelerating results. The test is $298 and is available after your first month of treatment.

Related Reading

• Mounjaro Medicine
• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.